Introduction {#s0001}
============

The genus *Thymus* L. (Lamiaceae) includes 215 species divided in 8 sections, with the evolutionary centres in the Mediterranean area from where it spreads to Europe, Asia, Northern America and Abyssinia, as well as to Greenland (Morales [@CIT0028]). Many species of this genus are used throughout the world in the traditional medicine and are nowadays important species in food, cosmetics and pharmaceutics (Nabavi et al. [@CIT0029]). For this reason, the evaluation of the phytochemical composition of different *Thymus* species can be considered fundamental for possible uses of the different plants in pharmaceutical, cosmetic and food products. A large number of studies were conducted especially on *T. vulgaris* L., a spice used in many regions of the world and one of the most important herbal drugs used as an antibacterial agent (Nabavi et al. [@CIT0029]). However, several species of the genus remain unexplored and deserve attention of scientists. Among them *T. alternans* Klokov is endemic to Carpathian regions and can be considered a neglected species of the genus *Thymus* (Klokov [@CIT0019]). *Thymus alternans* grows in dry meadows and hilly areas of Carpathian regions up to 1100 m above the sea level (Mártonfi [@CIT0025]; Načhyčhko [@CIT0030]). This species belongs to the Sect. *Serpyllum* (Miller) Bentham, Subsect. *Alternantes* Klokov, and taxonomically is widely accepted by specialists of the genus *Thymus*, as well as in the IPNI (The International Plant Names Index, [www.ipni.org](http://www.ipni.org)) database. Actually, *T. alternans* is recognized as a well distinguished taxon, characterized by sympodial branching with terminal fertile branch and alelotrichous indument (Mártonfi [@CIT0025]). The taxon belongs to the group of tetraploid taxa with 2 *n* = 4 × = 56 (Mártonfi & Mártonfiová [@CIT0026]) and is probably closely related to the species *T. nummularius* M. Bieb. and *T. pseudonummularius* Klokov et Des.-Shost. from Caucasus.

*Thymus alternans* has been frequently employed in the folk medicine of the regions in which occurs, often together with *T. pulegioides* L., with which it shares the same habitat. Owing to the polymorphism occurring in many *Thymus* species, including *T. serpyllum* s.l., which makes their identification very problematic, spontaneous plants of *T. alternans* are often used together with those of *T. pulegioides* (both belonging to the sect. *Serpyllum*) as an ingredient of the drug called '*Serpylli herba*', which is included in the European Pharmacopoeia ([@CIT0010]).

Continuing our research on secondary metabolites from unexplored species of the genus *Thymus* growing in Slovakia (Maggi et al. [@CIT0024]), the present work reports a comprehensive phytochemical analysis on polar phenolics, triterpenes, and volatile constituents obtained from the flowering aerial parts of *T. alternans* growing in Slovakia. Extracts obtained with solvents of increasing polarity were analyzed by HPLC-MS^n^ and were further subjected to extensive chromatographic separations, leading to the isolation of 12 compounds that were fully characterized by 1D and 2D NMR. Furthermore, hydrodistilled essential oils (EOs) from different samples were obtained and the quali-quantitative compositions were carefully investigated by GC-FID and GC-MS. Finally, the purified triterpene constituents as well as the EO were assayed for *in vitro* cytotoxic activity on a panel of human cancer cell lines.

Materials and methods {#s0002}
=====================

Plant material {#s0003}
--------------

Aerial parts of *T. alternans* were collected in the time of flowering on 16 June 2014 by Albert Rákai and Erik Ducár in three different localities in Bukovské vrchy hills in eastern Slovakia ([Figure 1](#F0001){ref-type="fig"}). These localities are: 1. the village of Runina, path across the fields; 49°4'32.34" N; 22°24'29.68" E; 572 m a.s.l. (voucher specimen KO 31164); 2. the village of Topoľa, near the bridge over the small river 'Ulička'; 49°3'11.46" N; 22°21'14.32" E; 398 m a.s.l. (KO 31165); 3. the village of Nová Sedlica, path across the forest; 49°3'14.95" N; 22°31'8.13" E; 452 m a.s.l. (KO 31166). Plants were identified by the specialist of the genus *Thymus*, Pavol Mártonfi, and voucher specimens are deposited in the KO herbarium (Herbarium of the Botanical Garden, P. J. Šafárik University, Košice, Slovakia). Plant samples were then stored in absence of light and at r.t. (ca. 22 °C) until completely dry.

![Distribution of the collection sites of *T. alternans* in Slovakia.](IPHB_A_1291689_F0001_C){#F0001}

HPLC, HPLC-MS, flash chromatography and semi-preparative HPLC {#s0004}
-------------------------------------------------------------

Silica gel plates (cod. 5171 Merck) and silica gel (60 mesh) were acquired from Sigma (Milan, Italy). Solvents were acquired from Carlo Erba (Milan). Varian Intelliflash flash chromatograph was used for preparative chromatography. A Varian 920 liquid chromatograph was used for semi-preparative HPLC. ESI-MS measurements were performed on a Varian 500 MS ion trap spectrometer. HPLC-DAD analyses were performed on an Agilent 1100 chromatographic system with Diode Array (1100 series). HPLC-MS was performed using a Varian 212 binary chromatograph hyphenated with a Varian 500 MS ion trap spectrometer.

NMR analysis {#s0005}
------------

1D and 2D NMR spectra were obtained on Bruker AVANCE 300 MHz and Bruker AVANCE III 400 MHz spectrometers, dissolving the samples in deuterated methanol. 2D experiments, namely, COSY, HSQC-DEPT, HMBC, TOCSY and NOESY were performed on a Bruker AVANCE III 400 MHz spectrometer and were used for structure elucidation.

Analysis of nonvolatile constituents {#s0006}
------------------------------------

Aerial parts of *Thymus alternans* (130 g dry material) collected in Nová Sedlica were chopped and extracted with *n*-hexane (100 mL) at room temperature for 10 min in an ultrasound bath (NE extract). Extraction was repeated twice yielding a brown residue. Solvent was removed and the residue was extracted with dichloromethane (100 mL) at room temperature for 10 min in an ultrasound bath, repeating the extraction twice (DM extract). Residual plant material was then extracted with methanol (100 mL) in an ultrasound bath, repeating the extraction twice (ME extract). Solvents were removed under vacuum, yielding a semi-solid dark-brown residue (NE 0.6%, DM 1.88%, ME 3.4%). Preliminary investigation on NE extract showed the presence of lipids, thus this fraction was discharged. DM extract (2.11 g) was applied to a pre-packed silica-gel column Supel Flash Cartridge, 80 g, 40--60 μm silica. Loaded column was eluted with cyclohexane (2 column volumes), then gradually adding acetone (up to 50%) to increase polarity of the eluent. Finally, the column was eluted with 100% methanol. Ninety-eight fractions (25 mL) were collected and pooled on the basis of their TLC chromatographic behaviour in nine different fractions: A (101.4 mg), B (27.4 mg), C (849.7 mg), D (80.2 mg), E (196 mg), F (94.7 mg), G (345.1 mg), H (397.2 mg), I (212.1 mg). The purification of fractions E, F, G, H by semi-preparative HPLC was performed using a PLRP-S 100 Å column (8 μm) as stationary phase. HPLC conditions were as follows: 0.1% formic acid in water (A) and acetonitrile (B) were used as eluents; gradient elution started from 20% (B), then in 30 min to 80% (B); the flow rate was 1.5 mL/min and the injection volume was 100 μL. Monitored wavelength was 205 nm. Isolated compounds were T1 (22 mg), T2 (15 mg), T3 (12 mg), T4 (10 mg), T5 (10 mg) and T6 (25 mg); NMR assignments are reported in [supplementary material](http://dx.doi.org/10.1080/13880209.2017.1291689).

ME extract (1.9 g) was charged on Supel Flash Cartridge, 120 g, 40--60 μm silica and eluted in isocratic mode with a 10:5:0.5 mixture of dichloromethane, methanol and water, respectively. Fifty fractions were collected (50 mL) and then pooled in 10 fractions on the basis of TLC behaviour. Fractions 4 (450 mg), 5 (300 mg) and 6 (350 mg) were then used for semi-preparative HPLC. Semi-preparative reverse-phase HPLC was performed using an Agilent XDB C-18 (2.1 × 150 mm, 5 μm) stationary phase and eluting the column with a gradient of 1% formic acid in water (A) and acetonitrile (B), as follows: 0 min, 10% B; 30 min, 85% B; 35 min, 85% B. Flow rate was 4 mL/min; the monitored wavelengths were 254, 280 and 350 nm; the injection volume was 100 μL. The isolated compounds were P1 (35 mg), P2 (14 mg), P3 (15 mg), P4 (12 mg), P5 (18 mg), P6 (11 mg) and P7 (14 mg), NMR assignments are reported in [Supplementary](http://dx.doi.org/10.1080/13880209.2017.1291689) information.

Hydrodistillation {#s0007}
-----------------

Dry aerial parts (187--257 g) were cut into small pieces, inserted into 6 L flasks filled with 3.5 L of deionized water and subjected to hydrodistillation using a Clevenger-type apparatus until no more oil was obtained. The oil yield was determined on a dry weight basis, by calculating the moisture content by leaving plant material in a stove at 105 °C for 8 h. The pure EO was stored in a sealed vial protected from light at −20 °C before chemical analysis and biological assays.

GC-FID and GC-MS analyses {#s0008}
-------------------------

Volatile components of *T. alternans* were analyzed on an Agilent 4890D instrument coupled to an ionization flame detector (FID). Separation was achieved on an HP-5 capillary column (5% phenylmethylpolysiloxane, 30 m, 0.32 mm i.d.; 0.25 μm film thickness; J and W Scientific, Folsom, CA), using the following temperature program: 5 min at 60 °C, then 4 °C/min up to 220 °C, then 11 °C/min up to 280 °C, held for 15 min. Injector and transfer line temperatures were 280 °C; He was the mobile phase, with a flow rate of 1.8 mL/min; split ratio was 1:34. A standard mixture of aliphatic hydrocarbons (C8--C30; Sigma, Milan) diluted in *n*-hexane was used to determine the retention indices (RIs) of peaks. Oil samples were diluted to 1:100 in *n*-hexane and 1 μL of the solution was injected into GC system. Analyses were performed in triplicate and the mean values were reported. Data analysis was carried out by HP3398A GC Chemstation software (Hewlett Packard, Rev. A.01.01). Quantification of volatiles was performed by peak-area normalization considering the response factors at FID equal to 1. GC-MS analysis was carried out on an Agilent 6890N gas chromatograph equipped with a 5973N mass spectrometer and using a HP-5 MS (5% phenylmethylpolysiloxane, 30 m, 0.25 mm i.d., 0.1 μm film thickness; J & W Scientific, Folsom) capillary column. The temperature program was the same as that reported above. Injector and transfer line temperatures were 280 °C; He was used as the mobile phase, with a flow rate of 1 mL/min; split ratio was 1:50; acquisition mass range was 29--400 *m/z*. Mass spectra were acquired in electron-impact (EI) mode with an ionization voltage of 70 eV. Oil samples were diluted to 1:100 in *n*-hexane, and 2 μL of the solution was injected into GC-MS system. Data analysis was done by MSD ChemStation software (Agilent, Version G1701DA D.01.00). The major EO constituents were identified by comparison with authentic standards available in the laboratory. Otherwise, the peak assignment was carried out by comparison of retention indices (RIs) and mass spectra (MS) with respect to those reported in commercial (Adams [@CIT0001]; NIST 08 [@CIT0031]; FFNSC 2 [@CIT0011]) and home-made libraries.

Cell cultures {#s0009}
-------------

Human breast (MDA-MB 231), colon (HCT-15 and HCT116), lung (U1810) and pancreatic (BxPC3) carcinoma cell lines together with melanoma (A375) cells were obtained from American Type Culture Collection (ATCC, Rockville, MD). Human cervical carcinoma (A431) cells were kindly provided by Prof. F. Zunino (Division of Experimental Oncology B, Istituto Nazionale dei Tumori, Milan, Italy). Cell lines were maintained in the logarithmic phase at 37 °C in a 5% carbon dioxide atmosphere using the following culture media, containing 10% fetal calf serum (Euroclone, Milan, Italy), antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin) and 2 mM [l]{.smallcaps}-glutamine: (i) RPMI-1640 medium (Euroclone) for HCT-15, A431, BxPC3, HCT116 and U1810 cells; (ii) DMEM (Sigma Chemical Co.) for A375 and MDA-MB 231 cells.

Cytotoxicity assays {#s0010}
-------------------

The MTT assay (MTT: 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide) was used as a relative measure of cell viability. Briefly, (3-8) × 10^3^ cells/well, dependent upon the growth characteristics of the cell line, were seeded in 96-well microplates in growth medium. After 24 h, the medium was removed and replaced with fresh medium containing the compound to be studied at the appropriate concentration (0.1--30 μM for isolated compounds, 1--100 μg/mL for EO). Triplicate cultures were established for each treatment. After 72 h, each well was treated with 10 μL of a 5 mg/mL MTT solution in phosphate-buffered saline (PBS) and, after 4 h of incubation, 100 μL of a sodium dodecylsulfate (SDS) solution in 0.01 M HCl were added. After an overnight incubation, the extent of MTT reduction was quantified spectrophotometrically using a microplate reader by absorbance measurement at 540 nm. The mean absorbance for each drug dose was expressed as a percentage of the control, untreated, well absorbance and plotted vs. drug concentration. Cytotoxicity is expressed as the concentration of compound inhibiting cell growth by 50% (IC~50~). The IC~50~ values, the drug concentrations that decrease the mean absorbance at 570 nm to 50% of that of untreated control wells, were calculated using GraphPad Prism 4 (GraphPad Software, S. Diego, CA). The final value is the mean ± S.D. of at least three independent experiments performed in triplicate.

Results and discussion {#s0011}
======================

LC-MS^n^ and NMR analysis {#s0012}
-------------------------

The HPLC-MS^n^ analysis of the methanolic extract from aerial parts of *T. alternans* allowed the identification of several phenolic constituents on the basis of pseudomolecular \[M-H\]^−^ ions and their relative fragmentation pathways, as summarized in [Table 1](#t0001){ref-type="table"}.

###### 

Non-volatile compounds extracted from *T. alternans*, tentatively identified on the basis of mass fragmentation spectra.

  Identified compound                                                        \[M-H\]^−^ and fragments
  -------------------------------------------------------------------------- --------------------------
  Luteolin-3-*O*-glucopyranoside[^a^](#TF1){ref-type="table-fn"}             447, 285,175
  Luteolin-7-*O*-glucopyranoside[^a^](#TF1){ref-type="table-fn"}             447, 285,175
  Luteolin-7-*O*-rutinoside[^a^](#TF1){ref-type="table-fn"}                  593, 285, 175
  Chrysoeriol-hexoside                                                       461, 446, 299, 284, 256
  Methoxy luteolin-hexoside                                                  461, 447, 285, 256, 175
  Chrysoeriol-7-*O*-hexosyl-deoxyhexoside                                    923, 461, 285, 175
  Rosmarinic acid hexoside                                                   521, 367, 359, 191
  Esculin[^a^](#TF1){ref-type="table-fn"}                                    339, 177
  Rosmarinic acid[^a^](#TF1){ref-type="table-fn"}                            359, 161
  Caffeic acid-hexoside                                                      341, 179, 89
  3′-*O*-(8″-*Z*-Caffeoyl) rosmarinic acid[^b^](#TF2){ref-type="table-fn"}   537, 493, 359
  Caffeic acid derivative                                                    377, 341, 179
  647, 601, 341, 179                                                         
  3'-*O*-methyl- rosmarinic acid[^b^](#TF2){ref-type="table-fn"}             377, 161, 133, 105
  Apigenin-7-*O*-glucopyranoside[^a^](#TF1){ref-type="table-fn"}             431, 269, 175
  Rosmarinic acid derivative                                                 493, 359, 161, 133

Structure identity confirmed by injection of reference compound.

The compound was assigned on the basis of literature data.

Some of the identified constituents could not be assigned to a single compound due to the presence of possible different isomers and due to the non-availability of reference compounds. Thus, in order to establish correct structures, we decided to isolate them. Chromatographic separations starting from flash chromatography and then using semi-preparative HPLC allowed the isolation of seven phenolic derivatives whose structures were elucidated by 1D and 2D NMR and mass spectrometric analyses ([Figure 2](#F0002){ref-type="fig"}). The^1^H, HSQC and HMBC spectra of compound P1 allowed the identification of luteolin, and the presence of a glycosidic residue that was assigned to a glucopyranoside unit. Glycosidation position was deduced from HMBC correlations observed from H-1~glc~ (δ 4.88) and C-4′ (δ 145.2) and from the NOESY correlation observed from H-1~glc~ and H-3′ (δ 6.56); thus the compound P1 was assigned to luteolin-4′-*O*-β-[d]{.smallcaps}-glucopyranoside. The compound P2 showed similar NMR data compared to P1 except for the presence of a methoxy signals (δ 3.95) and the glycosidation position that has been revealed by the HMBC correlation observed from the H-1~glc~ and the C-7 (δ 162.3) thus allowing to assign to compound P2 the structure of chrysoeriol-7-*O*-β-[d]{.smallcaps}-glucopyranoside (Agrawal & Bansal [@CIT0002]). Compound P3 was assigned to chrysoeriol-5-*O*-β-[d]{.smallcaps}-glucopyranoside (Agrawal & Bansal [@CIT0002]) on the basis of NOESY correlation observed from H-1~glc~ (δ 6.70) and H-6 (δ 6.96) and due to the HMBC correlation observed from H-1~glc~ and C-5 (δ 160.5). The compound P4 presented the apigenin as aglycone and the glycosidation position was revealed by the NOESY correlations observed from the H-1~glc~ (δ 5.10), H-6 and H-8 (δ 6.82 and 6.51) as well as by the HMBC correlation observed between H-1~glc~ and C-7 (δ 158.6) allowing the assignment to apigenin-7-*O*-β-[d]{.smallcaps}-glucopyranoside (Agrawal & Bansal [@CIT0002]). The rosmarinic acid structure was assigned to P5 due to the presence of a *trans* double bond supported by a pair of doublet at δ 7.51 and 6.26 (*J* = 15.85), as well as to signals ascribable to two 1,3,4 trisubstituted aromatic rings and a 2-hydroxy-propanoic substituent. Compound P6 presented a similar NMR spectrum characterized by signals ascribable to a glucopyranosil moiety that resulted to be linked to the rosmarinic acid to position 3′ due to NOESY correlation observed from the H-1~glc~ (δ 4.30) and H-2′ (δ 6.70) being the rosmarinic acid-3′-*O*-β-[d]{.smallcaps}-glucopyranoside P6 (Claire et al. [@CIT0007]). The structure of caffeic acid-3-*O*-β-[d]{.smallcaps}-glucopyranoside was assigned to compound P7 and the glycosidation position was deduced by NOESY correlations from H-1~glc~ (δ 4.37) and H-2 (δ 6.79) (Agrawal & Bansal [@CIT0002]).

![Structures of the isolated phenolic derivatives.](IPHB_A_1291689_F0002_B){#F0002}

The chromatographic separation from the lipophilic fraction yielded the isolation of six triterpenes (T1-T6) ([Figure 3](#F0003){ref-type="fig"}). The NMR spectra (H, HSQC, HMBC, COSY, NOESY) of the different compounds were similar and the analysis and comparison with the literature data allowed the characterization of the isolated compounds. The NMR spectrum of T1 is characterized by the presence of six tertiary methyl groups at *δ* 0.68, 0.69, 0.76, 0.84, 1.01 and 1.25 and two secondary methyl signals 0.79 (3H, d, *J* = 6.5 Hz) and 0.92 (3H, d, *J* = 6.3 Hz,), and a hydroxyl methyne signal at *δ* 3.50 as well as three olefinic protons, two at δ 5.11 and one at *δ* 5.33. ^13^C-NMR shifts and heteronuclear correlations allowed the assignment of structure to 3*α*-hydroxy-urs-12,15-diene, that was previously reported by Gosh et al. ([@CIT0014]) from *Croton bonplandianum* Bail. T2 and T3 were assigned to the well-known α- and β-amyrin (that were also compared with authentic standard available in the lab). ^1^H-NMR spectrum of compound T4 presented six quaternary methyl groups and two secondary methyl groups as doublets at δ 0.93 and 1.02, and a broad doublet at δ 5.50 (assigned to position H-15). The data were in agreement with previously published for isoursenol (Zhang et al. [@CIT0039]; Shan et al. [@CIT0033]). Compound T5 was assigned to epitaraxerol characterized by the presence of eight quaternary methyl groups and the olefinic signal at δ 5.50 assigned to position H-15 (Ahiahonu & Goodenowe [@CIT0003]). Finally, compound T6 was assigned to oleanolic acid by comparison with authentic standard.

![Structures of the isolated triterpenes.](IPHB_A_1291689_F0003_B){#F0003}

Essential oil analysis {#s0013}
----------------------

The composition of the EOs hydrodistilled from the flowering aerial parts of *T. alternans* is reported in [Table 2](#t0002){ref-type="table"}. A total of 71 volatile constituents were identified in the three samples analyzed, accounting for 91.0--93.2% of the total compositions. The EOs were mainly composed of terpenoids, notably oxygenated monoterpenes (35.3--39.1%), oxygenated sesquiterpenes (22.5--34.1%), monoterpene hydrocarbons (5.1--15.6%) and sesquiterpene hydrocarbons (12.2--15.1%). The sesquiterpene alcohol (*E*)-nerolidol was the most abundant component in all three oils analyzed (15.8--31.4%). Geranial (6.8--7.7%), linalool (1.7--6.4%), geraniol (3.3--6.2%) and neral (4.9--5.4%) were the most representative compounds among oxygenated monoterpenes. Germacrene D (6.7--7.4%) and (*E*)-β-ocimene (2.6--7.0%) were the predominant compounds among sesquiterpene and monoterpene hydrocarbons, respectively. The three EOs did not show relevant differences in qualitative composition each other. Only quantitative variation was noticed among them. For instance, the population from the village of Topoľa exhibited the highest levels of oxygenated monoterpenes (39.1%) and sesquiterpenes (34.1%), with the major amount of (*E*)-nerolidol (31.4%). On the other hand, the population from Nová Sedlica showed the highest levels of monoterpene hydrocarbons (15.6%) which were mainly represented by (*E*)-β-ocimene (7.0%), and minor amounts of oxygenated sesquiterpenes (22.5%), among which (*E*)-nerolidol attained the lowest level (15.8%).

###### 

Composition of EOs obtained from three populations of *Thymus alternans* growing in Slovakia (NS -- village of Nová Sedlica, RUN -- village of Runina, POL -- village of Topoľa. For details of localities see part Plant material).

  N.   Component[^a^](#TF3){ref-type="table-fn"}   RI[^b^](#TF4){ref-type="table-fn"}   RI LIT.[^c^](#TF5){ref-type="table-fn"}   Area%[^d^](#TF6){ref-type="table-fn"}   ID[^e^](#TF7){ref-type="table-fn"}          
  ---- ------------------------------------------- ------------------------------------ ----------------------------------------- --------------------------------------- ------------------------------------ ------ --------
  1    α-Thujene                                   916                                  924                                       0.1                                     tr[^f^](#TF8){ref-type="table-fn"}          RI, MS
  2    α-Pinene                                    921                                  932                                       0.3                                     0.1                                  tr     Std
  3    Camphene                                    934                                  946                                       0.5                                     0.1                                  0.1    Std
  4    Sabinene                                    959                                  969                                       tr                                      tr                                   tr     RI, MS
  5    β-Pinene                                    962                                  974                                       0.3                                     0.2                                  0.1    Std
  6    1-Octen-3-one                               968                                  972                                       0.2                                     0.1                                  tr     RI, MS
  7    1-Octen-3-ol                                974                                  974                                       1.6                                     1.1                                  1.4    Std
  8    3-Octanone                                  979                                  979                                       0.2                                     0.1                                  0.1    RI, MS
  9    Myrcene                                     981                                  988                                       4.0                                     1.9                                  1.3    Std
  10   3-Octanol                                   990                                  988                                       0.2                                     0.2                                  0.1    RI, MS
  11   Α-terpinene                                 1009                                 1014                                      0.4                                     0.3                                  0.1    RI, MS
  12   *p*-Cymene                                  1017                                 1020                                      0.3                                     0.3                                  0.1    Std
  13   Limonene                                    1020                                 1024                                      0.4                                     0.3                                  0.2    Std
  14   1,8-Cineole                                 1021                                 1026                                      0.7                                     0.3                                  0.4    Std
  15   (*Z*)-β-Ocimene                             1032                                 1032                                      1.0                                     0.5                                  0.4    RI, MS
  16   (*E*)-β-Ocimene                             1041                                 1044                                      7.0                                     4.3                                  2.6    RI, MS
  17   γ-Terpinene                                 1050                                 1054                                      1.0                                     1.0                                  0.2    Std
  18   *cis*-Sabinene hydrate                      1057                                 1065                                      2.4                                     2.3                                  0.7    RI, MS
  19   Terpinolene                                 1079                                 1086                                      0.2                                     0.2                                  0.1    Std
  20   *trans*-Sabinene hydrate                    1089                                 1098                                      0.3                                     0.3                                  0.1    RI, MS
  21   Linalool                                    1095                                 1095                                      2.7                                     1.7                                  6.4    Std
  22   *n*-Undecane                                1100                                 1100                                      0.2                                     0.1                                         Std
  23   1-Octen-3-yl acetate                        1110                                 1110                                      0.1                                     0.6                                  0.1    RI, MS
  24   *cis*-*p*-Menth-2-en-1-ol                   1113                                 1118                                      tr                                      0.2                                  0.1    RI,MS
  25   *allo*-Ocimene                              1124                                 1128                                      0.1                                     tr                                          Std
  26   Camphor                                     1132                                 1141                                      1.1                                     0.4                                  1.1    Std
  27   *trans*-Chrysanthemal                       1141                                 1153                                      0.2                                     0.3                                  0.2    RI, MS
  28   Nerol oxide                                 1149                                 1154                                      tr                                      0.1                                  0.1    RI, MS
  29   Isoborneol                                  1154                                 1155                                      1.1                                     0.5                                  1.0    Std
  30   Terpinen-4-ol                               1166                                 1174                                      1.8                                     1.8                                  1.0    Std
  31   Isogeranial                                 1178                                 1174                                      0.4                                     0.4                                  0.4    RI, MS
  32   α-Terpineol                                 1181                                 1186                                      0.5                                     0.3                                  0.5    Std
  33   Nerol                                       1222                                 1227                                      1.9                                     4.9                                  3.1    Std
  34   Citronellol                                 1225                                 1223                                      0.1                                     0.1                                  0.1    Std
  35   Thymol, methyl ether                        1229                                 1232                                      tr                                      tr                                   tr     RI, MS
  36   Neral                                       1234                                 1235                                      5.1                                     5.4                                  4.9    Std
  37   Carvacrol, methyl ether                     1236                                 1241                                                                              0.1                                         RI, MS
  38   Geraniol                                    1251                                 1249                                      3.3                                     6.0                                  6.2    Std
  39   Linalool acetate                            1254                                 1254                                      2.9                                     tr                                   2.4    RI, MS
  40   Geranial                                    1265                                 1264                                      6.8                                     7.7                                  7.2    Std
  41   Isobornyl acetate                           1276                                 1283                                      tr                                      tr                                   tr     Std
  42   Carvacrol                                   1299                                 1298                                                                              0.5                                         Std
  43   δ-Elemene                                   1325                                 1335                                      0.1                                     0.1                                         RI, MS
  44   Neryl acetate                               1360                                 1359                                      3.6                                     1.5                                  2.3    Std
  45   β-Bourbonene                                1369                                 1387                                      1.8                                     1.0                                  1.3    RI, MS
  46   Geranyl acetate                             1379                                 1379                                      0.3                                     0.9                                  1.1    RI, MS
  47   (*E*)-caryophyllene                         1402                                 1417                                      1.5                                     1.0                                  1.6    Std
  48   β-Copaene                                   1413                                 1430                                      0.2                                     0.2                                  0.2    RI, MS
  49   α-Humulene                                  1436                                 1454                                      0.2                                     0.4                                  0.2    Std
  50   *allo*-Aromadendrene                        1443                                 1458                                      0.7                                     0.1                                  0.1    RI, MS
  51   *cis*-Cadina-1(6),4-diene                   1449                                 1461                                                                                                                   0.1    RI, MS
  52   (*E*)-β-Farnesene                           1450                                 1454                                                                              0.1                                         RI, MS
  53   Germacrene D                                1465                                 1484                                      6.7                                     7.4                                  7.4    RI, MS
  54   Bicyclogermacrene                           1480                                 1500                                      0.5                                     0.5                                  0.2    RI, MS
  55   α-Muurolene                                 1487                                 1500                                      0.2                                     tr                                   0.1    RI, MS
  56   β-Bisabolene                                1498                                 1505                                      1.5                                     0.7                                  1.3    RI, MS
  57   (*E*,*E*)-α-Farnesene                       1501                                 1505                                      0.3                                     0.1                                  0.1    RI, MS
  58   δ-Cadinene                                  1510                                 1522                                      1.1                                     0.2                                  0.4    RI, MS
  59   β-Sesquiphellandrene                        1512                                 1521                                      0.2                                     0.4                                  tr     RI, MS
  60   α-Cadinene                                  1533                                 1537                                      0.1                                     tr                                          RI, MS
  61   Hedycaryol                                  1536                                 1546                                      2.9                                     3.6                                  1.4    RI, MS
  62   (*E*)-Nerolidol                             1559                                 1561                                      15.8                                    26.4                                 31.4   Std
  63   Germacrene D-4-ol                           1559                                 1574                                      tr                                      tr                                   tr     RI, MS
  64   Viridiflorol                                1584                                 1590                                      0.2                                                                                 Std
  65   γ-Eudesmol                                  1615                                 1630                                      0.4                                     0.1                                  0.2    RI, MS
  66   *epi*-α-Cadinol                             1626                                 1638                                      0.4                                     0.1                                  0.1    RI, MS
  67   *epi*-α-Muurolol                            1626                                 1640                                      0.4                                     0.3                                  0.2    RI, MS
  68   β-Eudesmol                                  1631                                 1649                                      0.2                                     0.2                                  0.1    RI, MS
  69   α-Eudesmol                                  1635                                 1652                                      0.3                                     0.3                                  0.2    RI, MS
  70   α-Cadinol                                   1648                                 1652                                      1.8                                     0.8                                  0.6    RI, MS
  71   *n*-Nonacosane                              2900                                 2900                                      0.1                                     0.2                                  0.3    Std
       Total identified (%)                                                                                                       91.0                                    91.4                                 93.2    
       Oil yield (%)                                                                                                              0.2                                     0.2                                  0.1     
       Grouped compounds (%)                                                                                                                                                                                           
       Monoterpene hydrocarbons                                                                                                   15.6                                    9.2                                  5.1     
       Oxygenated monoterpenes                                                                                                    35.3                                    34.6                                 39.1    
       Sesquiterpene hydrocarbons                                                                                                 15.1                                    12.2                                 12.9    
       Oxygenated sesquiterpenes                                                                                                  22.5                                    32.1                                 34.1    
       Others                                                                                                                     2.6                                     2.4                                  2.0     

Compounds are in order of elution from a HP-5MS column.

Retention index on HP-5MS column.

Retention index taken from literature (Adams, [@CIT0001]; NIST [@CIT0008], [@CIT0031]; FFNSC [@CIT0002], [@CIT0011]).

Percentage values are means of three determinations, with a RSD% for the main components below 10% in all cases.

Identification methods: MS, by comparison with the mass libraries Wiley, Adams and NIST 08; RI, by comparison with RIs-containing libraries (Adams, [@CIT0001]; NIST [@CIT0008], [@CIT0031]; FFNSC [@CIT0002], [@CIT0011]); Std, by comparison with authentic standard.

tr, traces (mean value below 0.1%).

The main volatile component of *T. alternans*, the tertiary alcohol (*E*)-nerolidol, is one of the most important volatile components of kiwi (*Actinidia chinensis*), tea (especially Oolong tea), strawberry, grape, snapdragon and maize, and is approved and used as a food flavouring agent by the FDA. Nerolidol is involved in attracting pollinators and in defence against predators (Green et al. [@CIT0015]). Interestingly, nerolidol is currently under study as a skin penetration enhancer for transdermal drugs. Furthermore, it was shown to inhibit carcinogenesis on azoxymethane-induced neoplasia in rats (Wattenberg [@CIT0038]), and it was effective as an antioxidant *in vivo* (Nogueira Neto et al. [@CIT0032]), as an antimicrobial and anti-biofilm agent against *Staphylococcus aureus* (Lee et al. [@CIT0021]) and *Candida albicans* (Curvelo et al. 2014), and as anti-parasitic versus *Leishmania* species (Arruda et al. [@CIT0004]) and acari (de Assis Lage et al. [@CIT0009]). Recently, nerolidol was proven to exert antinociceptive activity mediated by the GABAergic system, and anti-inflammatory activity decreasing TNF-α and IL-1β proinflammatory cytokines (Fonsêca et al. [@CIT0012]).

The present work constitutes the first investigation on volatile components of *T. alternans.* In all the populations considered in the present work, the phenolic compounds thymol and carvacrol, which are considered as the most frequent EO constituents in *Thymus* taxa, have not been found or have been detected in scarce amount (0.5%). This may be due to adaptation of Slovak populations to low temperatures. Accordingly, it has been reported that the production of phenolic compounds in *Thymus* species is higher in warmer and drier regions, while non-phenolic compounds usually accumulate in higher quantities in colder and damper areas (Keeler & Tu [@CIT0018]). Therefore, the *T. alternans* populations investigated are to be included in the nerolidol-chemotype, as already reported for other species of the same genus such as *T. serpyllum* (Jamali et al. [@CIT0016]), *T. caucasicus* (Jamzad et al. [@CIT0017]), *T. praecox* (Vidic et al. [@CIT0037]), *T. atticus* (Tzakou & Constantinidis [@CIT0036]), *T. pulegioides* (Mockute & Bernotiene [@CIT0027]) and *T. zygioides* (Baser et al. [@CIT0005]). As regards the related *T. roegneri*, one paper reported on the EO composition of plants growing in Turkey (Tümen et al. [@CIT0035]). In this case thymol (37.15%), *p*-cymene (12.94%) carvacrol (7.76%) and β-bisabolene (6.96%) were found as the major components, while (*E*)-nerolidol was completely missing. The different chemical profile obtained for *T. alternans* may represent an additional evidence at the basis of the taxonomical differentiation of the two species.

Cytotoxic activity of isolated triterpenes and EO from thymus alternans on tumour cells {#s0014}
---------------------------------------------------------------------------------------

The cytotoxic activity of the six isolated triterpenes and EO isolated from plants collected near the village of Nová Sedlica was evaluated by the MTT assay. The triterpenes (T1-T6) were tested on a panel of five human tumour cell lines including examples of pancreatic (BxPC3), colorectal (HCT-15), cervical (A431), and lung (U1810) cancers as well as of melanoma (A375). For comparison purposes, the cytotoxicity of cisplatin, one of the most widely used anticancer drugs, and of betulinic acid, a naturally occurring triterpene that has been shown to possess a promising anticancer activity (Chudzik et al. [@CIT0006]), were evaluated under the same experimental conditions. IC~50~ values, calculated from the dose-survival curves obtained after 72 h of drug treatment, are shown in [Table 3](#t0003){ref-type="table"}.

###### 

*In vitro* cytotoxic activity of triterpenes isolated from aerial parts of *T. alternans* collected in Nová Sedlica, Slovakia. Cells (5--8 × 104·mL ^−^ ^1^) were treated for 72 h with increasing concentrations of tested compounds.

  IC~50~(μM) ± S.D.                                                             
  ------------------- ------------- -------------- ------------- -------------- -------------
  T1                  1.57 ± 0.72   0.88 ± 0.22    4.54 ± 1.06   0.52 ± 0.24    2.86 ± 0.83
  T2                  1.26 ± 0.12   1.46 ± 0.13    4.98 ± 1.14   1.84 ± 0.31    2.25 ± 1.05
  T3                  0.48 ± 0.67   0.67 ± 0.09    2.03 ± 0.98   0.42 ± 0.13    0.98 ± 0.21
  T4                  1.45 ± 0.56   1.69 ± 0.72    4.85 ± 1.32   1.42 ± 0.73    3.59 ± 1.31
  T5                  0.87 ± 0.32   2.42 ± 1.05    3.28 ± 1.09   1.84 ± 0.91    2.93 ± 1.13
  T6                  0.45 ± 0.10   0.54 ± 0.08    2.16 ± 0.83   0.19 ± 0.09    1.62 ± 0.85
  Betulinic acid      ND            6.85 ± 2.18    8.96 ± 2.83   4.28 ± 1.35    ND
  Cisplatin           2.06 ± 1.01   15.53 ± 2.48   1.96 ± 0.84   10.17 ± 1.65   0.76 ± 0.85

S.D. = standard deviation. ND = not detected. Cell viability was evaluated by means of MTT test. IC~50~ values were calculated by the dose--response curves by means of four parameter logistic model (*p* \< 0.05).

Cytotoxicity data showed that all the considered triterpenes are endowed with a considerable activity, which is greater than that exerted by the reference drug betulinic acid against all tested cancer cell lines. On the other hand, the antiproliferative activity of all isolated triterpenes was even higher than that of cisplatin on melanoma (A375, *p* \< 0.05), colon cancer (HCT-15, *p* \< 0.05) and pancreatic cancer (BxPC3, *p* \< 0.05) cells. Among all isolated derivatives, T3 was the most effective, with a mean IC~50~ value of roughly 0.9 μM, about 6.7 times lower than that calculated for cisplatin (mean IC~50 ~=~ ~6.1 μM, *p* \< 0.05). Similarly, the carboxylated derivative T6 exhibited a cytotoxicity profile comparable to that of T3, with an average IC~50~ value of about 1 μM (*p* \< 0.05). Notably, the cytotoxicity of T3 and T6 exceeded that of the metallodrug by a factor of about 25 against HCT-15 colon cancer cells, which are barely chemosensitive to cisplatin. On average, T1, T2, T4 and T5 showed a quite similar pattern of response against all tested cell lines, eliciting average IC~50~ values of about 2 μM, roughly three times lower than those obtained with the reference drugs (mean IC~50~ of 6.7 and 6.1 μM for betulinic acid and cisplatin, respectively, *p* \< 0.05).

Considering the similar pair of compounds T2/T3 (differencing each other only in the structure of ring E), T3 showed higher cytotoxic activity against all the tested cell lines compared to T2. Thus, minor changes in the structure of these compounds may induce moderate changes in the observed activity. On the other hand, considering the pair T4/T5, also these differing in the structure of ring E, T5 showed higher activity against A375, A431 and U1810 cell lines compared to T4. Therefore, a systematic Structure Activity Relationship (SAR) study may be useful in order to assess notable key point in the basic structure bearing useful improvement of activity.

Concerning possible mechanism of action on tumour cells, betulinic acid is considered as a promising anticancer agent acting through activation of the mitochondrial pathway of apoptosis in cancer cells (Fulda & Kroemer [@CIT0013]). On the other hand, no data are available on the mode of action of T1-T6. For this reason, further studies on *T. alternans* triterpenes are needed in order to evaluate their possible role on apoptosis. It is worthy to underline that these compounds are well known for possessing moderate toxic effects when administered orally, thus are considered as significant models for the development of new classes of antiproliferative compounds.

The cytotoxic effects of *T. alternans* EO were evaluated on A375, MDA-MB 231, and HCT116 human tumour cell lines. Tumour cells were treated with various concentrations (1--100 μg/mL) of EO for 72 h and then submitted to the MTT assay. As shown in [Table 4](#t0004){ref-type="table"}, the EO showed notable growth inhibition effects on all human tumour cells in a dose-dependent manner (*p* \< 0.05). The inhibition was remarkable with IC~50~ values of 5.51, 5.96 and 8.45 μg/mL on A375, MDA-MB 231 and HCT116, respectively. These IC~50~ values are commonly considered as promising for anticancer drug discovery and development. In fact, according to the standards of the National Cancer Institute (NCI), a plant extract may be considered as active and potential source of anticancer drugs if its IC~50~ is lower than 20 μg/mL (Cordell et al. [@CIT0008]). The observed cytotoxicity was not specific toward a cancer cell line and it cannot be attributed to a compound or few compounds as shown in the composition of EO. In order to compare the obtained results with literature we considered the previously published data on some of the main constituents. (*E*)-nerolidol, the main compound present in *T. alternans* EO, has been shown to be cytotoxic on renal cell adenocarcinoma ACHN, the hormone-dependent prostate carcinoma LNCaP, human lung carcinoma A-549 and colon adenocarcinoma DLD-1 (Loizzo et al. [@CIT0022]; Sylvestre et al. [@CIT0034]). The IC~50~ values of this compound determined by us on tumour cell lines were 2.92, 4.13 and 5.76 μg/mL for A375, HCT116 and MDA-MB 231, respectively, but the differences in the various types of tumour cells and the possible variation in the assay protocol should be also considered. The antiproliferative activity of neral and geranial, the two isomers of citral, were tested in our previous study (Maggi et al. [@CIT0023]), and IC~50~ values ranged from 5.73 to 11.3 μg/mL on MDA-MB 231 and A375, respectively. Germacrene D has been reported to inhibit the growth of MDA-MB-231, MCF7, Hs 578T, PC-3, and Hep-G2 cell lines (Kuźma et al. [@CIT0020]). Neryl acetate and nerol were also assayed and showed lower cytotoxic activity against the tested tumour cell lines ([Table 4](#t0004){ref-type="table"}). No data are available in the literature regarding cytotoxic activity of (*E*)-β-ocimene. The concentrations of (*E*)-nerolidol (15.8%), (*E*)-β-ocimene (7%), geranial (6.8%), germacrene D (6.7%), and neral (5.1%) cannot fully explain the observed cytotoxic activity. This means that other minor compounds contributed to the activity, taking into account that synergism between constituents may increase the total antiproliferative activity exhibited by the EO. *T. alternans* EO presented an excellent inhibitory activity against human tumour cell lines with IC~50~ values close to those of the cisplatin (*p* \< 0.05). These results suggest further investigations on the possible mechanisms of action.

###### 

*In vitro* cytotoxic activity of *T. alternans* EO[^a^](#TF10){ref-type="table-fn"}.

  IC~50~ (μg/ml) ± S.D.[^b^](#TF11){ref-type="table-fn"}                                     
  -------------------------------------------------------- ---------------- ---------------- ----------------
  Essential oil                                            5.51 ± 0.34      5.9 6 ± 0.46     8.45 ± 0.61
  (*E*)-Nerolidol                                          2.92 ± 0.09      5.76 ± 0.29      4.13 ± 0.18
                                                           (13.13 ± 0.43)   (25.90 ± 1.31)   (18.57 ± 0.81)
  Neryl acetate                                            28.05 ± 1.27     27.37 ± 1.87     45.61 ± 2.83
                                                           (142.9 ± 6.47)   (139.5 ± 9.53)   (232.4 ± 14.4)
  Nerol                                                    75.83 ± 3.97     24.44 ± 1.66     33.49 ± 4.53
                                                           (491.6 ± 25.7)   (158.4 ± 10.8)   (217.1 ± 29.4)
  Positive control                                                                            
  Cisplatin                                                0.43 ± 0.045     2.94 ± 0.23      2.42 ± 0.21
                                                           (1.43 ± 0.15)    (9.80 ± 0.76)    (8.06 ± 0.70)

Sample was obtained from population growing in Nová Sedlica.

IC~50~= The concentration of compound that affords a 50% reduction in cell growth (after 72 h of incubation).

Human malignant melanoma cell line.

Human breast adenocarcinoma cell line.

Human colon carcinoma cell line. Bracketed IC~50~ values are expressed in μM ± S.D.

Conclusions {#s0015}
===========

Phytochemical investigations on *T. alternans* allowed identification of the main phytoconstituents of the plants aerial parts, showing the presence of glycosylated flavonoids and rosmarinic acid, pentacyclic triterpenes and EO. Triterpenes and EO exhibited significant antiproliferative activity against a panel of tumour cell lines. In particular, the pentacyclic triterpenes showed improved activity compared to the reference compounds cisplatin and betulinic acid. (*E*)-nerolidol, the main volatile component of *T. alternans* EO, appeared to afford the major contribution to the cytotoxic activity of the EO. This work pointed out the great chemical diversity of *T. alternans* phytocomplex. In addition, the significant cytotoxic activity of some of the isolated triterpenes underlines the possible role of the plant as a potential source of bioactive compounds for therapeutical applications.
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